{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T22:09:55Z","timestamp":1789769395927,"version":"4.0.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejim.2022.11.028","type":"journal-article","created":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T02:09:49Z","timestamp":1669428589000},"page":"81-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis"],"prefix":"10.1016","volume":"108","author":[{"given":"Maria Domenica","family":"Cappellini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4660-821X","authenticated-orcid":false,"given":"Antonio","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Giuffrida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorina","family":"Giona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2022.11.028_bib0001","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.ejim.2022.11.028_bib0002","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2022.11.028_bib0003","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/cells8040364","article-title":"GBA, Gaucher Disease, and Parkinson\u2019s Disease: from genetic to clinic to new therapeutic approaches","volume":"8","author":"Riboldi","year":"2019","journal-title":"Cells"},{"issue":"Suppl 1","key":"10.1016\/j.ejim.2022.11.028_bib0004","first-page":"S12","article-title":"Gaucher disease types 1 and 3: phenotypic characterization of large populations from the ICGG Gaucher Registry","volume":"90","author":"Grabowski","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0005","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2022.11.028_bib0006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-017-0572-x","article-title":"Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)","volume":"12","author":"McGovern","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejim.2022.11.028_bib0007","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.beem.2014.08.004","article-title":"Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening","volume":"29","author":"Kingma","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2022.11.028_bib0008","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/gim.2017.7","article-title":"Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency","volume":"19","author":"McGovern","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2022.11.028_bib0009","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ymgme.2016.05.001","article-title":"Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): literature review and report of new cases","volume":"118","author":"Cassiman","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.ejim.2022.11.028_bib0010","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ajh.20908","article-title":"Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention","volume":"82","author":"Mistry","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0011","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/ajh.26276","article-title":"Clinical outcomes after 4.5 years of eliglustat therapy for Gaucher disease type 1: phase 3 ENGAGE trial final results","volume":"96","author":"Mistry","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0012","unstructured":"Xenpozyme. [cited September 15, 2022]; Available from: https:\/\/www.accessdata.fda.gov\/scripts\/opdlisting\/oopd\/detailedIndex.cfm?cfgridkey=132900."},{"key":"10.1016\/j.ejim.2022.11.028_bib0013","unstructured":"Xenpozyme. [cited August 9, 2022]; Available from:https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/xenpozyme-epar-product-information_en.pdf."},{"key":"10.1016\/j.ejim.2022.11.028_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2022.03.021","article-title":"A randomized, placebo-controlled clinical trial evaluating olipudase alfa enzyme replacement therapy for chronic acid sphingomyelinase deficiency (ASMD) in adults: one-year results","author":"Wasserstein","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2022.11.028_bib0015","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41436-021-01156-3","article-title":"One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency","volume":"23","author":"Diaz","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.ejim.2022.11.028_bib0016","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ajh.26559","article-title":"Splenomegaly: dare to think rare","volume":"97","author":"Scaramellini","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0017","first-page":"119","article-title":"Burden of illness in acid sphingomyelinase deficiency: a retrospective chart review of 100 patients","volume":"41","author":"Cox","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ejim.2022.11.028_bib0018","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajh.21888","article-title":"A reappraisal of Gaucher disease-diagnosis and disease management algorithms","volume":"86","author":"Mistry","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0019","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/ejh.12596","article-title":"A multicentre observational study for early diagnosis of Gaucher disease in patients with Splenomegaly and\/or Thrombocytopenia","volume":"96","author":"Motta","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0020","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1038\/s41598-021-82296-z","article-title":"Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia","volume":"11","author":"Motta","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejim.2022.11.028_bib0021","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.dld.2019.12.005","article-title":"AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement","volume":"52","author":"Nascimbeni","year":"2020","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.ejim.2022.11.028_bib0022","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13023-018-0782-x","article-title":"A pilot screening of high-risk Gaucher disease children using dried blood spot methods in Shandong province of China","volume":"13","author":"Lei","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ejim.2022.11.028_bib0023","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cca.2020.03.016","article-title":"High risk screening for Gaucher disease in patients with splenomegaly and\/or thrombocytopenia in China: 55 cases identified","volume":"506","author":"Huang","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ejim.2022.11.028_bib0024","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.12960","article-title":"Gaucher disease screening at a general adult hematology tertiary care centre: a prospective study","volume":"41","author":"Russell","year":"2019","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.ejim.2022.11.028_bib0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ymgme.2017.08.002","article-title":"Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians","volume":"122","author":"Mehta","year":"2017","journal-title":"Mol Genet Metab"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620522004149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:38:25Z","timestamp":1760607505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620522004149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":25,"alternative-id":["S0953620522004149"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.028","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: An algorithm to support the diagnosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2022.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}